JNJing Nie

Jing Nie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jing Nie has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomaterials and biofabrication in the Netherlands: state of the art in 2026

    by Jing Nie, Eric Farrell, Matthew B. Baker, David Kilian, Lorenzo Moroni, Farhad Sanaei, Mani Diba, Sander Leeuwenburgh, Amir A. Zadpoor, Carlijn V. C. Bouten, et al.

    Biomaterials and biofabrication are multidisciplinary and rapidly evolving fields that enable innovations that are crucial for addressing current healthcare challenges. The Netherlands has a broad, active, and collaborative research community that is developing advanced biomaterials and cutting.edge biofabrication methods, with applications in tissue engineering, regenerative medicine, in vitro disease modeling, and biomedical devices. Dutch researchers have pioneered advanced biofabrication, supramolecular and inorganic chemistry for creating biomaterials, organoids and organ-on-chip in vitro platforms, and regenerative medicine. This paper presents recent work on biomaterials and biofabrication and their applications from 11 prominent research institutions across the Netherlands, and it describes joint initiatives that target broader goals within the field. Contributors from each institution provide insights into recent progress, key scientific contributions, and forward-looking perspectives. By presenting the state-of-the-art research landscape, this article serves as a reference for scientists actively engaged in or planning to initiate biofabrication or biomaterials-related research, offering guidance on technology selection, experimental design, academic collaboration, and translational development.

  • Open Access

    3D printing for tissue/organ regeneration in China

    by Chaofan He, Jiankang He, Chengtie Wu, Changshun Ruan, Qi Gu, Yongqiang Hao, Yang Wu, Shuo Bai, Xiaoxiao Han, Liliang Ouyang, et al.

    As surgical procedures transition from conventional resection to advanced tissue-regeneration technologies, human disease therapy has witnessed a great lea


  • Open Access

    A Cell Pre‐Wrapping Seeding Technique for Hydrogel‐Based Tubular Organ‐On‐A‐Chip

    by Jing Nie, Sha Lou, Andreas M. A. O. Pollet, Manon van Vegchel, Carlijn V. C. Bouten, Jaap M. J. Den Toonder

    Organ‐on‐a‐chip (OOC) models based on microfluidic technology are increasingly used to obtain mechanistic insight into (patho)physiological processes in humans, and they hold great promise for application in drug development and regenerative medicine. Despite significant progress in OOC development, several limitations of conventional microfluidic devices pose challenges. First, most microfluidic systems have rectangular cross sections and flat walls, and therefore tubular/ curved structures, like blood vessels and nephrons, are not well represented. Second, polymers used as base materials for microfluidic devices are much stiffer than in vivo extracellular matrix (ECM). Finally, in current cell seeding methods, challenges exist regarding precise control over cell seeding location, unreachable spaces due to flow resistances, and restricted dimensions/geometries. To address these limitations, an alternative cell seeding technique and a corresponding workflow is introduced to create circular cross‐sectioned tubular OOC models by pre‐wrapping cells around sacrificial fiber templates. As a proof of concept, a perfusable renal proximal tubule‐on‐a‐chip is demonstrated with a diameter as small as 50 µm, cellular tubular structures with branches and curvature, and a preliminary vascular‐renal tubule interaction model. The cell pre‐wrapping seeding technique promises to enable the construction of diverse physiological/pathological models, providing tubular OOC systems for mechanistic investigations and drug development.